| Regulation of NK cell activation and effector functions by the IL-12 family of cytokines: the case of IL-27 NW Zwirner, A Ziblat Frontiers in immunology 8, 25, 2017 | 138 | 2017 |
| NK cells restrain spontaneous antitumor CD8+ T cell priming through PD-1/PD-L1 interactions with dendritic cells XLR Iraolagoitia, RG Spallanzani, NI Torres, RE Araya, A Ziblat, ... The Journal of Immunology 197 (3), 953-961, 2016 | 114 | 2016 |
| IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness A Ziblat, CI Domaica, RG Spallanzani, XLR Iraolagoitia, LE Rossi, ... European journal of immunology 45 (1), 192-202, 2015 | 84 | 2015 |
| Histone deacetylase inhibitors impair NK cell viability and effector functions through inhibition of activation and receptor expression LE Rossi, DE Avila, RG Spallanzani, A Ziblat, MB Fuertes, L Lapyckyj, ... Journal of leukocyte biology 91 (2), 321-331, 2012 | 83 | 2012 |
| Human M2 macrophages limit NK cell effector functions through secretion of TGF-β and engagement of CD85j SY Nuñez, A Ziblat, F Secchiari, NI Torres, JM Sierra, XL Raffo Iraolagoitia, ... The Journal of Immunology 200 (3), 1008-1015, 2018 | 69 | 2018 |
| Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56bright Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation A Ziblat, SY Nuñez, XL Raffo Iraolagoitia, RG Spallanzani, NI Torres, ... Frontiers in Immunology 8, 1959, 2018 | 45 | 2018 |
| Expression and functional role of α7 nicotinic receptor in human cytokine-stimulated natural killer (NK) cells SR Zanetti, A Ziblat, NI Torres, NW Zwirner, C Bouzat Journal of Biological Chemistry 291 (32), 16541-16552, 2016 | 45 | 2016 |
| Regulatory dendritic cells restrain NK cell IFN-γ production through mechanisms involving NKp46, IL-10, and MHC class I–specific inhibitory receptors RG Spallanzani, NI Torres, DE Avila, A Ziblat, XLR Iraolagoitia, LE Rossi, ... The Journal of Immunology 195 (5), 2141-2148, 2015 | 33 | 2015 |
| Expansion of CD11b+Ly6G+Ly6Cint cells driven by medroxyprogesterone acetate in mice bearing breast tumors restrains NK cell effector functions RG Spallanzani, T Dalotto-Moreno, XL Raffo Iraolagoitia, A Ziblat, ... Cancer Immunology, Immunotherapy 62, 1781-1795, 2013 | 25 | 2013 |
| Tumor-Experienced Human NK Cells Express High Levels of PD-L1 and Inhibit CD8+ T Cell Proliferation JM Sierra, F Secchiari, SY Nuñez, XLR Iraolagoitia, A Ziblat, AD Friedrich, ... Frontiers in immunology 12, 745939, 2021 | 24 | 2021 |
| Circulating and tumor-infiltrating NK cells from clear cell renal cell carcinoma patients exhibit a predominantly inhibitory phenotype characterized by overexpression of CD85j … A Ziblat, XLR Iraolagoitia, SY Nuñez, NI Torres, F Secchiari, JM Sierra, ... Frontiers in Immunology 12, 681615, 2021 | 18 | 2021 |
| Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric protein N Torres, MV Regge, F Secchiari, AD Friedrich, RG Spallanzani, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 18 | 2020 |
| PyNTTTTGT and CpG Immunostimulatory Oligonucleotides: Effect on Granulocyte/Monocyte Colony-Stimulating Factor (GM-CSF) Secretion by Human CD56+ (NK … JM Rodriguez, J Marchicio, M López, A Ziblat, F Elias, J Fló, RA López, ... PLoS One 10 (2), e0117484, 2015 | 17 | 2015 |
| In silico guided discovery of novel class I and II Trypanosoma cruzi epitopes recognized by T cells from Chagas’ disease patients GR Acevedo, NA Juiz, A Ziblat, L Perez Perri, MC Girard, MS Ossowski, ... The Journal of Immunology 204 (6), 1571-1581, 2020 | 9 | 2020 |
| The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncology F Secchiari, SY Nuñez, JM Sierra, A Ziblat, MV Regge, ... Oncoimmunology 11 (1), 2104991, 2022 | 8 | 2022 |
| Tumor-experienced human NK cells express PD-L1 and display immunoregulatory functions MB Fuertes, XLR Iraolagoitia, A Ziblat, SY Nuñez, NI Torres, F Secchiari, ... The Journal of Immunology 198 (1_Supplement), 56.2-56.2, 2017 | 3 | 2017 |
| Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy A Ziblat, BL Horton, EF Higgs, K Hatogai, A Martinez, JW Shapiro, ... Cell Reports 43 (5), 2024 | 2 | 2024 |
| 328 Batf3 dendritic cells and 4–1BB/4–1BB ligand axis are required at the effector phase within the tumor microenvironment for anti-PD-L1 efficacy A Ziblat, B Horton, E Higgs, K Hatogai, T Gajewski Journal for ImmunoTherapy of Cancer 9 (Suppl 2), A354-A354, 2021 | 1 | 2021 |
| Tumor-experienced NK cells inhibit T cell proliferation and activation through PD-L1 JM Sierra, XLR Iraolagoitia, F Secchiari, A Ziblat, SY Nuñez, NI Torres, ... Cancer Research 78 (13_Supplement), 704-704, 2018 | 1 | 2018 |
| Expression of Ligands of the Activating Receptor NKG2D in Myelodysplastic Syndrome and Acute Myelogenous Leukemia Blasts and Lymphoid Cells F Secchiari, M Iastrebner, SY Nuñez, M Tamashiro, NI Torres, JM Sierra, ... Leukemia Research 1 (55), S123, 2017 | 1 | 2017 |
